Acurx Pharmaceuticals
ACXP
ACXP
23 hedge funds and large institutions have $4.24M invested in Acurx Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.07% more ownership
Funds ownership: 0.34% → 0.4% (+0.07%)
65% less call options, than puts
Call options by funds: $284K | Put options by funds: $822K
Holders
23
Holding in Top 10
–
Calls
$284K
Puts
$822K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$205K | |
| 3 | +$172K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$120K |
| 5 |
State Street
Boston,
Massachusetts
|
+$109K |
Top Sellers
| 1 | -$750K | |
| 2 | -$28K | |
| 3 | -$20.8K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$19.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$15.2K |